Camlin Fine Sciences Limited
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
What Camlin files
- Others88
- Investor Meet28
- Important23
- Updates14
- Board Meeting11
- PPTs8
Camlin Fine Sciences (CFS) achieved its highest-ever quarterly revenue in Q1FY27 at ₹519.9 Cr, marking a 27.5% YoY jump. Despite this, consolidated EBITDA stood at ₹17.6 Cr (3.4% margin), and the company posted a Net Loss of ₹31.8 Cr. Gross margins were impacted by higher raw material prices and limited...
Camlin Fine Sciences reported FY26 revenue of 1,723.3 Cr, with Q4 FY26 revenue at 424.8 Cr and EBITDA at 21.2 Cr (5.0% margin). Profitability was impacted by rising interest costs, currency fluctuations, and conflict, alongside competition pressing Straights segment prices. The Blends business, however, maintained steady 17% annual growth. The...
Camlin Fine Sciences reported Q3 FY26 revenue of Rs 457.2 Cr (+6.1% YoY) and 9M FY26 revenue of Rs 1,340.6 Cr (+9% YoY). Profitability was hit by 'Straights' pricing pressure, resulting in a Q3 net loss of Rs 27.9 Cr and a 9M loss of Rs 38.2 Cr. However, the...
Here's a concise, retail-friendly summary for Camlin Fine Sciences: **Camlin Fine Sciences Q2/H1 FY26 Recap:** Revenue climbed 10.2% YoY to Rs 459.8 Cr for Q2, and 10.7% YoY for H1 to Rs 883.4 Cr. Adjusted EBITDA hit Rs 33.4 Cr (7.3% margin) in Q2. Significant win: Continuing operations losses (PBT)...
Here is the financial summary for Camlin Fine Sciences Limited: **1. Financial Highlights:** Q1FY26 consolidated revenue was Rs 428.6 Cr, a sequential dip. Adjusted EBITDA sharply fell to Rs 19.0 Cr (4.5% margin) from Rs 59.4 Cr (13.6%), primarily due to sluggish Specialty Ingredients Straights. Blends business showed strong growth....